275 related articles for article (PubMed ID: 29656834)
1. Controlling ticks and tick-borne diseases…looking forward.
de la Fuente J
Ticks Tick Borne Dis; 2018 Jul; 9(5):1354-1357. PubMed ID: 29656834
[TBL] [Abstract][Full Text] [Related]
2. Tick vaccines: current status and future directions.
de la Fuente J; Contreras M
Expert Rev Vaccines; 2015; 14(10):1367-76. PubMed ID: 26289976
[TBL] [Abstract][Full Text] [Related]
3. Targeting a global health problem: Vaccine design and challenges for the control of tick-borne diseases.
de la Fuente J; Contreras M; Estrada-Peña A; Cabezas-Cruz A
Vaccine; 2017 Sep; 35(38):5089-5094. PubMed ID: 28780117
[TBL] [Abstract][Full Text] [Related]
4. Translational biotechnology for the control of ticks and tick-borne diseases.
de la Fuente J
Ticks Tick Borne Dis; 2021 Sep; 12(5):101738. PubMed ID: 34023540
[TBL] [Abstract][Full Text] [Related]
5. High throughput discovery and characterization of tick and pathogen vaccine protective antigens using vaccinomics with intelligent Big Data analytic techniques.
De La Fuente J; Villar M; Estrada-Peña A; Olivas JA
Expert Rev Vaccines; 2018 Jul; 17(7):569-576. PubMed ID: 29953298
[TBL] [Abstract][Full Text] [Related]
6. Strategies for new and improved vaccines against ticks and tick-borne diseases.
de la Fuente J; Kopáček P; Lew-Tabor A; Maritz-Olivier C
Parasite Immunol; 2016 Dec; 38(12):754-769. PubMed ID: 27203187
[TBL] [Abstract][Full Text] [Related]
7. Tick vaccines and the transmission of tick-borne pathogens.
de la Fuente J; Kocan KM; Blouin EF
Vet Res Commun; 2007 Aug; 31 Suppl 1():85-90. PubMed ID: 17682852
[TBL] [Abstract][Full Text] [Related]
8. Interactomics and tick vaccine development: new directions for the control of tick-borne diseases.
Artigas-Jerónimo S; De La Fuente J; Villar M
Expert Rev Proteomics; 2018 Aug; 15(8):627-635. PubMed ID: 30067120
[TBL] [Abstract][Full Text] [Related]
9. Vaccinomics, the new road to tick vaccines.
de la Fuente J; Merino O
Vaccine; 2013 Dec; 31(50):5923-9. PubMed ID: 24396872
[TBL] [Abstract][Full Text] [Related]
10. Modeling tick vaccines: a key tool to improve protection efficacy.
de la Fuente J; Estrada-Peña A; Contreras M
Expert Rev Vaccines; 2020 Mar; 19(3):217-225. PubMed ID: 32192377
[No Abstract] [Full Text] [Related]
11. Prevention and control strategies for ticks and pathogen transmission.
de La Fuente J; Kocan KM; Contreras M
Rev Sci Tech; 2015 Apr; 34(1):249-64. PubMed ID: 26470461
[TBL] [Abstract][Full Text] [Related]
12. Advances in the identification and characterization of protective antigens for recombinant vaccines against tick infestations.
de la Fuente J; Kocan KM
Expert Rev Vaccines; 2003 Aug; 2(4):583-93. PubMed ID: 14711342
[TBL] [Abstract][Full Text] [Related]
13. Targeting the tick-pathogen interface for novel control strategies.
de la Fuente J; Kocan KM; Almazan C; Blouin EF
Front Biosci; 2008 May; 13():6947-56. PubMed ID: 18508707
[TBL] [Abstract][Full Text] [Related]
14. Exposed and concealed antigens as vaccine targets for controlling ticks and tick-borne diseases.
Nuttall PA; Trimnell AR; Kazimirova M; Labuda M
Parasite Immunol; 2006 Apr; 28(4):155-63. PubMed ID: 16542317
[TBL] [Abstract][Full Text] [Related]
15. Innovative approaches for the control of ticks and tick-borne diseases.
de la Fuente J; Mazuecos L; Contreras M
Ticks Tick Borne Dis; 2023 Nov; 14(6):102227. PubMed ID: 37419001
[TBL] [Abstract][Full Text] [Related]
16. Applying proteomics to tick vaccine development: where are we?
Villar M; Marina A; de la Fuente J
Expert Rev Proteomics; 2017 Mar; 14(3):211-221. PubMed ID: 28099817
[TBL] [Abstract][Full Text] [Related]
17. Tick Bioactive Molecules as Novel Therapeutics: Beyond Vaccine Targets.
Murfin KE; Fikrig E
Front Cell Infect Microbiol; 2017; 7():222. PubMed ID: 28634573
[No Abstract] [Full Text] [Related]
18. Upcoming and future strategies of tick control: a review.
Ghosh S; Azhahianambi P; Yadav MP
J Vector Borne Dis; 2007 Jun; 44(2):79-89. PubMed ID: 17722860
[TBL] [Abstract][Full Text] [Related]
19. Vaccination with proteins involved in tick-pathogen interactions reduces vector infestations and pathogen infection.
Merino O; Antunes S; Mosqueda J; Moreno-Cid JA; Pérez de la Lastra JM; Rosario-Cruz R; Rodríguez S; Domingos A; de la Fuente J
Vaccine; 2013 Dec; 31(49):5889-96. PubMed ID: 24084474
[TBL] [Abstract][Full Text] [Related]
20. Current status and future prospects of multi-antigen tick vaccine.
Parthasarathi BC; Kumar B; Ghosh S
J Vector Borne Dis; 2021; 58(3):183-192. PubMed ID: 35170454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
